Stryker Dominates $3.6 Billion Robotic Knee Surgery Market as Rivals Race for Autonomous Solutions

Stryker's MAKO platform performs more than half of the world's robotic knee replacements, but competitors are betting autonomy will reshape the $17.81 billion orthopedic implant market. With over 3,000 MAKO systems installed globally and more than 50% of global knee implant procedures performed using its technology as of year-end 2025, Stryker has established commanding market share in the robotic knee replacement segment. Yet the competitive landscape is intensifying as rivals pursue different strategies to capture market share in a field where clinical outcomes are increasingly convergent and the next battlefield has shifted to autonomous capabilities.